Jacquet E, Pham F, Taouk B, Kerouani-Lafaye G, et al. Access to innovation through clinical trials and the national early access program for patients with lung cancer in France: focus on atezolizumab and durvalumab. Cancer Chemother Pharmacol 2023 Jul 13. doi: 10.1007/s00280-023-04556.
PMID: 37439816